Process for the preparation of standardized composition of arjunoglucoside from the bark of Terminalia arjuna

US10479749B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10479749-B2
Application numberUS-201816014401-A
CountryUS
Kind codeB2
Filing dateJun 21, 2018
Priority dateJun 21, 2017
Publication dateNov 19, 2019
Grant dateNov 19, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed is a novel process for the isolation of bioactive compounds from Terminalia arjuna. More specifically, the invention discloses a process for isolation and enrichment of bioactive compounds Arjunic acid, Arjunolic acid, Arjungenin, Arjunetin, Arjunoglucoside-I, Arjunoglucoside-II, and Catechin from the bark of Terminalia arjuna. The invention also discloses a composition standardized to contain 3% arjunoglucosides isolated from the bark of Terminalia arjuna.

First claim

Opening claim text (preview).

We claim: 1. A process for the isolation of standardized composition comprising of arjunoglucoside from bark of Terminalia arjuna , said process comprising steps of: (a) Charging Terminalia arjuna bark powder into an extractor, (b) Adding 3 volumes of ethanol or methanol to Terminalia arjuna bark powder and refluxing for 3 hours at 65 to 70° C., (c) Filtering the ethanol or methanol extract of step b) and concentrating under vacuum to get a brown coloured powder, (d) Dissolving the powder obtained from step c) into 5 volumes of de-mineralize water and stirring thoroughly for 1 hr at 50-55° C. to obtain a solution, (e) Transferring the solution from step d) to separating funnel and extracting with 2 volumes of ethyl acetate, 6 times, and separating the aqueous and organic layer, (f) Collecting and combining the ethyl acetate fractions 1-6 from step e and concentrating under vacuum to obtain brown coloured powder, (g) Loading the powder of step 1) into a silica gel and eluting with chloroform:methanol, (h) Identifying the compounds from step g) as Arjunic acid corresponding to STR#1, Arjunolic acid corresponding to STR#2, Arjungenin corresponding to STR#3, Arjunoglucoside-I corresponding to STR#4, Arjunoglucoside-II corresponding to STR#5, Arjunetin corresponding to STR#6, and catechin corresponding to STR#7 2. A process for enriching arjunoglucoside II, said process comprising steps of: (a) Charging Terminalia arjuna bark powder into an extractor, (b) Adding 3 volumes of ethanol or methanol to Terminalia arjuna bark powder and refluxing for 3 hours at 65 to 70° C., (c) Filtering the ethanol or methanol extract of step b) and concentrating under vacuum to get a brown coloured powder, Assay of arjunoglucoside-II by HPLC=0.55% w/w (d) Dissolving the powder obtained from step c) into 5 volumes of de-mineralize water and stirring thoroughly for 1 hr at 50-55° C. to obtain a solution, (e) Transferring the solution from step d) to separating funnel and extracting with 2 volumes of ethyl acetate, 6 times, and separating the aqueous and organic layer, (f) Collecting and combining the ethyl acetate fractions 1-6 from step e and concentrating under vacuum to obtain brown coloured powder, Assay of arjunoglucoside-II by HPLC=20-21% w/w. 3. A composition comprising at-least 3% arjunoglucosides wherein said composition comprises Arjunic acid corresponding to STR#1, Arjunolic acid corresponding to STR#2, Arjungenin corresponding to STR#3, Arjunoglucoside-I corresponding to STR#4, Arjunoglucoside-I corresponding to STR#5, Arjunetin corresponding to STR#6, and catechin corresponding to STR#7

Assignees

Inventors

Classifications

  • Antivirals · CPC title

  • Antineoplastic agents · CPC title

  • polycyclic · CPC title

  • Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine · CPC title

  • Myrtaceae (Myrtle family), e.g. teatree or eucalyptus · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10479749B2 cover?
Disclosed is a novel process for the isolation of bioactive compounds from Terminalia arjuna. More specifically, the invention discloses a process for isolation and enrichment of bioactive compounds Arjunic acid, Arjunolic acid, Arjungenin, Arjunetin, Arjunoglucoside-I, Arjunoglucoside-II, and Catechin from the bark of Terminalia arjuna. The invention also discloses a composition standardized t…
Who is the assignee on this patent?
Majeed Muhammed, Nagabhushanam Kalyanam, Bhat Beena, and 1 more
What technology area does this patent fall under?
Primary CPC classification C07C35/44. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).